Cationic Starch Nanoparticles for Enhancing CpG Oligodeoxynucleotide-Mediated Antitumor Immunity

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• CpG oligonucleotides (ODNs) show promise for immunotherapy but face challenges with nuclease degradation and poor cellular uptake.
• Current delivery methods like viral vectors have safety and cost limitations.

Purpose of the Study:

• To develop a novel, safe, and efficient delivery vector for CpG ODNs using modified starch.
• To evaluate the efficacy of the starch-based vector for enhancing CpG ODN delivery and antitumor activity.

Main Methods:

• Starch was modified via ultrasonication and amination (NH2-St) to create spherical nanoparticles (50 nm).
• Cationic NH2-St was used to encapsulate CpG ODNs, assessing loading capacity and protection against nuclease digestion.
• Cellular uptake and cytokine secretion from macrophages were evaluated.
• Tumor cell growth suppression was assessed in vitro.

Main Results:

• The fabricated NH2-St nanoparticles demonstrated good biocompatibility and high CpG ODN loading capacity (317 μg/mg).
• NH2-St effectively protected CpG ODNs from nuclease digestion and significantly enhanced cellular uptake.
• NH2-St/CpG complexes stimulated potent antitumor cytokine secretion from macrophages and suppressed tumor cell growth.

Conclusions:

• Starch-based nanoparticles offer a promising, biocompatible platform for delivering CpG ODNs in cancer immunotherapy.
• This novel delivery system overcomes key limitations of CpG ODNs, providing new hope for cancer treatment.